Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.
Document Type
Article
Publication Date
7-2021
Identifier
DOI: 10.1007/s11095-021-03076-y
Abstract
Purpose: A dataset of fraction excreted unchanged in the urine (fe) values was developed and used to evaluate the ability of preclinical animal species to predict high urinary excretion, and corresponding poor metabolism, in humans.
Methods: A literature review of fe values in rats, dogs, and monkeys was conducted for all Biopharmaceutics Drug Disposition Classification System (BDDCS) Class 3 and 4 drugs (n=352) and a set of Class 1 and 2 drugs (n=80). The final dataset consisted of 202 total fe values for 135 unique drugs. Human and animal data were compared through correlations, two-fold analysis, and binary classifications of high (fe ≥30%) versus low (
Results: Significant correlations were found between fe values for each animal species and human fe (p
Conclusions: Drugs with high urinary excretion in animals are likely to have high urinary excretion in humans. Animal models tend to underpredict the urinary excretion of unchanged drug in humans.
Journal Title
Pharmaceutical research
Volume
38
Issue
7
First Page
1139
Last Page
1156
Keywords
BDDCS; Fraction excreted unchanged; animal models; poorly-metabolized drugs; renal clearance
Recommended Citation
Bamfo NO, Hosey-Cojocari C, Benet LZ, Remsberg CM. Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans. Pharm Res. 2021;38(7):1139-1156. doi:10.1007/s11095-021-03076-y
COinS
Comments
Grant support